Natalizumab is effective in controlling the inflammatory rebound after its discontinuation and failure of an alternative treatment. Barroso B, Miquel M, Marasescu R, Demasles S, Krim E, Bonnan M Mult Scler Relat Disord. 2015 Jul; 4(4):380-2. PMID: 26195060. Abstract CommentRecommendBookmarkWatch